Yofumo Technologies Inc.

Yofumo Technologies Inc. specializes in organic cannabis decontamination solutions, offering innovative technology aimed at preserving the quality of cannabis while ensuring safety and compliance. Founded in 2015 and headquartered in Denver, US, Yofumo Technologies Inc. provides advanced decontamination solutions for the cannabis industry.

The company has raised USD 1. 5 mn in a SEED funding round led by MedScience Ventures on June 13, 2017. Javier Derderyan serves as the founder of the company, with HB Juengling as the CEO. It has successfully completed 2 deals to date.

Yofumo Technologies offers an innovative organic cannabis decontamination solution through its flagship product, Pro+ Cure. This technology remediates and decontaminates cannabis without harming the flower's terpenes or cannabinoids, appealing to cultivators focused on maintaining product quality. Pro+ Cure is EU-GMP CE certified and validated in facilities across four countries. The company serves a diverse clientele, including cannabis cultivators, processing facilities, and distributors, enhancing the quality and safety of their products across North America and parts of Europe.

Yofumo Technologies generates revenue through a business-to-business model, partnering with cannabis producers and processing facilities to implement its Pro+ Cure system. Clients typically engage in long-term partnerships that include service agreements for installation, maintenance, and training, ensuring a comprehensive approach to post-harvest product control. The pricing plans are structured for scalability, catering to varying needs within the cannabis industry. Yofumo Technologies plans to leverage its recent funding of USD 1.

5 mn from the SEED round to enhance its product offerings and explore new geographic markets. The company is focused on developing additional products that complement the Pro+ Cure system, targeting launches within the next two years. Additionally, Yofumo aims to expand its market presence further into Europe and North America, capitalizing on the growing legalization of cannabis in those regions.